Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing Dec 06, 2022 15:00 JST Read More
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing Dec 06, 2022 14:00 HKT/SGT Read More
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials Dec 06, 2022 11:00 HKT/SGT Read More
Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium Dec 01, 2022 19:09 HKT/SGT Read More
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index Nov 30, 2022 22:43 HKT/SGT Read More
エーザイ、11名の先端医療機関の専門家および8名のエーザイ研究者による「レカネマブ」の早期アルツハイマー病に対する臨床第III相Clarity AD検証試験結果の論文がthe New England Journal of Medicineに掲載 Nov 30, 2022 17:30 JST Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」の早期アルツハイマー病に対する臨床第III相Clarity AD検証試験結果を第15回アルツハイマー病臨床試験会議（CTAD）において発表 Nov 30, 2022 17:30 JST Read More
Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease at Clinical Trials on Alzheimer's Disease (CTAD) Conference Nov 30, 2022 09:21 HKT/SGT Read More
Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine Nov 30, 2022 08:31 HKT/SGT Read More
Eisai Announces Approval of Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Nov 29, 2022 18:28 HKT/SGT Read More
